Myelodysplastic Syndromes: Developing Drug and Biological Products for Treatment
Myelodysplastic Syndromes: Developing Drug and Biological Products for Treatment
Recommend0 recommendationsPublished in US National Health Agency Sources
Related Articles
Drug Overdose Deaths During COVID-19: A Historical Spike Among Latinos?
More Americans have died from a drug overdose in the last 12 months than at any other point in history. New research has found a historical 21% spike in drug overdose deaths amid COVID-19. This data comes during a pandemic that has disproportionately affected Latinos — moreover, it’s worsening already harsh historical inequities this group …
The post Drug Overdose Deaths During COVID-19: A Historical Spike Among Latinos? appeared first on Salud America.
FDA Approves New Drug for Alzheimer’s, But Scientists Divided Over Decision
The U.S. Food and Drug Administration approved a new drug called Aduhelm (aducanumab) to treat Alzheimer’s disease, the most common form of dementia. Many are applauding the drug and are encouraged by the scientific progress in a field that has long had limited treatment options. Alzheimer’s affects over 6.2 million people in the U.S., with …
The post FDA Approves New Drug for Alzheimer’s, But Scientists Divided Over Decision appeared first on Salud America.
Top California Democrats Clash Over How To Rein In Drug Industry Middlemen
California Gov. Gavin Newsom and state legislators in Sacramento seem to agree: Prescription drug prices are too high. But lawmakers and the second-term governor are…
HHS Selects the First Drugs for Medicare Drug Price Negotiation
For the first time, Medicare will be able to negotiate prices directly with drug companies, lowering prices on some of the costliest prescription drugs. For the first time, thanks to […]
The post HHS Selects the First Drugs for Medicare Drug Price Negotiation appeared first on Pennsylvania Office of Rural Health.
KFF Health News’ ‘What the Health?’: On Autism, It’s the Secretary’s Word vs. CDC’s
The Host Emmarie Huetteman KFF Health News Emmarie Huetteman, senior editor, oversees a team of Washington reporters, as well as “Bill of the Month” and KFF Health…